Dotan I

Publishing 2015–2020

Is this you? Claim this profile
2
Articles
790
Reads on Journament
40
Co-authors
2
Journals

This page collects the articles indexed under the name Dotan I. Profiles are grouped by name, so it can include work by someone else who shares it until the author claims the profile and confirms which papers are theirs.

Publications 2

  1. Sustained Corticosteroid-Free Clinical Remission During Vedolizumab Maintenance Therapy in Patients with Ulcerative Colitis on Stable Concomitant Corticosteroids During Induction Therapy: A Post Hoc Analysis of GEMINI 1
  2. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target

Possible papers by Dotan I 3

Published under a similar spelling of the name. Beside each paper is the evidence that it may be the same person, strongest first; "Same name only" means there is nothing else to go on.

  1. Microbial predictors of sustained clinical remission following the crohn’s disease exclusion diet in adults and microbiome shifts toward healthy paediatric controls
    as Iris Dotan Crohn s & Colitis 360 2026
    Same name only
  2. GLP-1 Receptor Agonist Exposure and Malignancy Risk in Patients With Endogenous Cushing’s Syndrome
    as Idit Dotan the journal of clinical endocrinology & metabolism 2026
    Same name only
  3. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations
    as Iris Dotan Journal of Crohn s and Colitis 2009
    Same name only

Under these spellings

Same person? Claim this profile, then add these papers one by one or combine a whole spelling.

Is this you?

Claim this profile to connect it to your account. You will be able to remove papers that are not yours, fold in other spellings of your name, and show your affiliation and photo here.

Also published as

Tick the other spellings that are you. Leave the rest.

An admin reviews every claim. Your account's name, email address and affiliation are shown to them too.

You need an account to claim. No password: we email you a sign-in link, and your claim is sent as soon as you are back.

Frequent co-authors

Publishes in